FindTrial
Sign In

Clinical Study of Fecal Microbiota Transplantation in the Treatment of Diarrhea Associated with Clostridium Difficile Infection in Kidney Transplant Recipients

Clinical Study of Fecal Microbiota Transplantation in the Treatment of Diarrhea Associated with Clostridium Difficile Infection in Kidney Transplant Recipients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055874
Enrollment
Unknown
Registered
2022-01-22
Start date
2022-01-23
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clostridium difficile infection

Interventions

Treatment group:Fecal Microbiota Transplantation in a single dose of 4.5U bacterial solution

Sponsors

Henan Province People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Kidney transplant recipients identified as CDI by Clostridium difficile and still unable to control diarrhea after drug treatment; 2. Aged 18 years and over; 3. Voluntarily sign informed consent.

Exclusion criteria

Exclusion criteria: 1.Complicated with acute parenteral infection; 2.Combined with acute graft rejection; 3.Diarrhea can be well controlled by drug treatment; 4.Any conditions that increase the risk of adverse events in the subject or quit midway.

Design outcomes

Primary

MeasureTime frame
Diarrhea symptoms cure effectively;Negative conversion ratio of clostridium difficile;—

Secondary

MeasureTime frame
Improvement of laboratory results;—

Countries

China

Contacts

Public ContactTian Xiangyong

Henan Province People's Hospital

tianxiangyong888@163.com+86 15333818352

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026